Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 6 | EJNMMI Radiopharmacy and Chemistry

Fig. 6

From: Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration

Fig. 6

A Clonogenic survival of PANC-1 and AsPC-1 cells following incubation with varying concentrations of [225Ac]Ac-DOTA-C595. Comparison of clonogenic survival following different treatments at equivalent concentrations of 1, 10 and 50 nM in B PANC-1 and C AsPC-1 cells. D intra-observer reliability testing. NB: B and C only display concentrations where all four treatments were used

Back to article page